DAFTAR PUSTAKA
Anonim.(2016). Peripheral Neurophaty. Medicinus, Volume 29(1): 3-5.
AHA [American Heart Association].2013. Guidelines for The Management of Patients With Ischemic Stroke : A Guidelines for Health Care Professionals From the American Heart Association/ American Stroke Association. Dallas : 2013.
Airagnes Guillaume, Antoine Pelissolo, Melanie Lavallee, Martine Flament. (2016) . Benzodiazepine Misuse in The Elderly : Risk Factors, Consequences, and Management. Journal of Current Psychiatry Reports , Volume 18:89
[AMA] American Medical Association Evidence-Based Guideline for the
Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).
JAMA. doi:10.1001/jama.2013.284427.
Alhasni, Eay., Ikawati Zullies. Perbandingan Efektifitas Pirasetam dan Sitikolin Pada Pasien Stroke Iskemik di Bangsal Rawat Inap RSUD Undata Palu. Thesis. Fakultas Farmasi : Universitas Gadjah Mada
[Askes] Asuransi Kesehatan Masyarakat. (2014). Pedoman Pelayanan BPJS. Jakarta : PT Askes
Baxter. 2008. Stocklye’s Drug Interactions 8th. London : Pharmaceutical Press.
Carda S, Cisari C, Invernizzi M et al. (2009). Osteoporosis after stroke: a review of the causes and potential treatments. Journal of Cerebrovasc Dis, Volume 28: 191-200
Caplan L R. 2009. Basic Pathology, Anatomy and Pathophysiology. In Caplan L
R. Caplan’s Stroke : A Clinical Appoarch 4th Edition. USA : Saunders Elsevier 22-84.
CDC [Centre for Disease Control]. 2016. Chronic Diseases: The Leading Causes of Death and Disability in the United States. Diakses pada 19 Oktober 2016 10.29WIBhttp://www.cdc.gov/chronicdisease/overview/
Culleton BF, Manns BJ, Zhang J, et al. Impact of anemia on hospitalization and mortality in older adults. Blood 2006;107:3841–3846.
Deaborn Jennifer L, Urrutia V C dan Zeiler S R (2014). Stroke and Cancer – A Complicated Relationship. J Neurol Transl Neurosci 2(1): 1039.
Depkes [Departement Kesehatan]b. 2009. PERMENKES No: 269. Kemenkes : Jakarta
Di Piro Joseph et al. 2008. Pharmacotheraphy : Pathophysiologic Approach 7th Edition. New York : Mc Graw Hill
Dahlan, M.Sofiyudin. 2010. Besaran Sample dan Cara Pengambilan Sampel dalam Penelitian Kedokteran dan Kesehatan. Salemba Medika : Jakarta
Doijad, R.C., Pathan, A.B., Pawar, N.B., Baraskar, S.S., Maske, V.D dan Gaikwad, S.L.,(2012). Therapeutic Applications of Citicoline and Piracetam as Fixed Dose Combination. Journal of Pharma and Bio Science, Volume 2(12):15-20.
Ekawati, Agustina dan Wiwik Afrida (2015) Hubungan Antara Lama Perawatan dengan Antrian Masuk Rumah Sakit Pada Pasien BPJS di RS Islam Jemursari Surabaya. Jurnal Ilmiah Kesehatan, Vol 8(1): 97-103.
Fahrisal. 2011. Drug Related Problems (DRP) pada Pasien Strok di ICU
(Intensive Unit Care) Rumah Sakit Stroke Nasional Bukit Tinggi. Skripsi. Universitas Andalas : Fakultas Farmasi.
Guiteras Anna Renom, Gabriele Meyer, Petra A Thurmann. The EU(7)-pim LIST : a list of potentially inappropriate medications for older people consented by experts form sevenEuropean countries. European Journal Clinical Pharamcology (2015) 71: 861-875
Hidayah, Noor Fatih.2016. Skripsi : Kontribusi Apoteker dalam Menangani Kejadian Drug Related Problems (DRP) pada Pasien Hipertensi Rawat Inap di RSUD Prof Dr.Margono Soekarjo. Universitas Muhammadiyah Purwokerto : Jawa Tengah.
Huri, Hasniza Zaman dan Hoo Fun We. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocrine Disorders2013,13:2
ICSI [ Institue for Clinical Systems Improvement].2012. Health Care Guidelines : Diagnosis and Initial Treatment of Ischemic Stroke. Institue for Clinical System Imrprovement Volume 10 July 2012.
ISFI [Ikatan Sarjana Farmasi Indonesia].2008. ISO Farmakoterapi. Jakarta : ISFI Penerbitan
control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectable. BMC Public Health 2013, 13:602.
Junaidi Iskandar. 2004. Panduan Praktis Pencegahan dan Pengobatan Stroke. Jakarta : PT Bhuana Ilmu Populer
Kemenkes [Kementrian Kesehatan]. 2013. Riset Kesehatan Dasar. Kementrian Kesehatan Indonesia : Jakarta.
Khalil Samir Helmy Assad, Robert Najem, Jorge Sison, Asad Riaz Kitchlew, Belong Chi, Kwo – Chang Ueng, Shelley Di Tommaso dan Abhijit Shete. (2015). Real – world effectiveness of amlodipin/valsartan and amlodipine/valsartan/hydrochlorothiazide in high ris patients and other subgroups. Journal of Vasc Healt Risk Manag, Volume 11 : 71 -78
Kumar S , PK Thakur, KK Jha and SK Shah. 2016. A Prospective Assesment of Polypharmacy Induced Drug Interactions With Corticosteroid. Journal of Medical College 6(15); 24 -29
KV Kirsten, Hege SB, Tron AM, Aasmund R. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Brit J Clin Pharmacol.2006,63:2187–2195
Mamosaki R, Yasunaga H, Matsui H, Fushimi K, Abo M.(2016). Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke. J Stroke Cerebrovasc Dis,
Volume 25(5):1035-1040
Manurung Minarti, Noor Diani, Agianto. Analisis Faktor Risiko Stroke pada Pasien Stroke Rawat Inap di RSUD Banjarbaru. Jurnal Dunia Kedokteran Volume : 3(1)
Meng Lee, Yi Ling Wu, Jeffrey L Saver, Hsuei Chen Lee, Jiann Der Lee, Ku Chou Chang, Chih Ying Wu, Tsong Hai Lee, Hui Hsuan Wang, Neal M Rao dan Brucee Ovbiagele. (2014). Is clopidogrel better than aspirin following breakthrough strokes while on aspirin ? A retrospective cohor study. BMJ Open 4(12)
Mkoko P, N Mokhele, M Ntsekhe, N A B Ntusi. Case Report: Digoxin Therapy in The Modern Management of Cardiovasculer Disease : An unsual but serious complication. S Afr Med J 2015;105(2): 154
Mycek Mary J, A H Richard, Champe PC. (2002). Farmakologi Ulasan
Bergambar Edisi 2. Penerjemah : Azwar Agoes dan Huriawati H.
Nastiti, Dian. (2011). Gambaran Faktor Kejadian Stroke pada Pasien Stroke Rawat Inap di Rumah Sakit Krakatau Medika Tahun 2011. Skripsi. Universitas Indonesia : FKIK
Martindale. (2009). The Complete Drug Refferences 36th Edition. Pharmaceutical Press : United Kingdom
Ningsih. 2004. Interaksi Obat Pada Pasien di Poliklinik Geriatri Perjan
RS Dr.Cipto Mangunkusumo Jakarta. Skripsi. Universitas Indonesia : Depok
NSA [National Stroke Association]. 2013. Diabetes and Stroke : Undersatnding the connection between diabetes and the increased risk of stroke.
Tersedia di http://www.stroke.org/. Diakses tanggal 27 Mei 2017 10:16WIB
Nursalam.2008. Konsep dan Penerapan Metodologi Penelitian Ilmu
Keperawatan. Salemba Medika : Jakarta.
Overgaard, Karsten MD. The Effects of Citicoline on Acute Ischemic Stroke: A Review. Journal of Stroke and Cerebrovascular Diseases, Vol. 23, No. 7 (August), 2014: pp 1764-1769
Perdossi [Perhimpunan Dokter Spesialis Syaraf Indonesia].2011. Guideline Stroke Tahun 2011. Jakarta : Perdossi
PCNE [Pharmaceutical Care Network Europe].2016. Classification for Drug Related Problems. Swiss : PCNE Foundation. Diakses di
http://www.pcne.org/working-groups/2/drug-related-problems pada 29 November 2016 pukul 15.07 WIB
Praja, Dini Setiya., Didik Hasmono dan Nailis Syifa. (2013). Studi Penggunaan Obat Neuroprotektan Pada Pasien Stroke Iskemik (Penelitian di Rumah Sakit Umum Dr.Saiful Anwar Malang). Pharmacy. Volume 10(02): 147 – 158.
Puspita, M dan Putro, G. 2008. Hubungan Gaya Hidup terhadap Kejadian Stroke di Rumah Sakit Umum daerah Gambiran Kediri. Buletin Penelitian Sistem Kesehatan, Volume 11 (3), hal 263-269.
Roger PA. Polypharmacy as a risk factor in the treatment of type 2 diabetes.Diabetes Spectrum2006,19(1):13–16.
Roozendaal, Van BW, Krass I. (2009). Development of an evidence-based
checklist forthe detection of drug related problems in type 2 diabetes.
Terjadinya Stroke Berulang pada Penderita Pasca Stroke. Semarang : FKIK UMS
Sitompul Fransiska, Maksum Radji, Anton Bahtiar. (2016). Evaluasi Penggunaan Antibiotik dengan Metode Gyssens pada Pasien Stroke Rawat Inap di RSUD Koja secara Retrospektif (Periode KJS dan BPJS). Jurnal Kefarmasian Indonesia. Volume : 6(1):30-38
Sofyan Aisyah Muhrini, Ika Yulieta Sihombing dan Yusuf Hamra. 2012.
Hubungan Umur, Jenis Kelamin, dan Hipertensi dengan Kejadian Stroke. Sulawesi Tenggara : FK UHO.
Syifa, Nailis., Ikawati Zullies., Inayati. (2010). Kajian Efetivitas Penggunaan Pirasetam dan Sitikolin Pada Pasien Stroke dengan Menggunakan The National Institue of Health Stroke Scale (NIHSS) di Bangsal Rawat Inap RS PKU Muhammadiyah Yogyakarta. Di dalam : Prosiding Seminar Nasional Eight Star Performance Pharmacist; Yogyakarta, 27 Desember 2010. Yogyakarta : Fakultas Farmasi UGM, Halaman 15-19.
T Cellin A , Seuma J dan Ramesh A. 2012. Assessment of Drug Related Problems in Stroke Patients Admitted to a South Indian Tertiary Care Teaching Hospital. Indian Journal of Pharmacy Practice Volume 5(4)
Taufiqurrohman dan Sari Merry Indah. (2016). The Benefit of Citicoline for Non Hemoragic Stroke Patient. Journal of Medula Unila . Volume 6(1) : 165 – 171
Thanacoody. 2012. Drug Interactions. Dalam Buku : Walker R dan Whittlesea, Editor. Clinical Pharmacy and Therapeutics 5th Edition. London: Churchill Livingstone Elsevier.
Thomas Novita Silvana, Matilda Susanto, Poppy K. Sasmita, A.P. Regina Satya W. Kontribusi Hipertensi dan Diabetes Mellitus Tipe 2 atau Keduanya Terhadap Stroke Berulang. Damianus Journal of Medicine; Vol.13 No.2 Juni 2014: hlm. 110-116
Tjay Hoan Tan dan Kirana Rahardja.2013. Obat – Obat Penting : Khasiat, Penggunaan dan Efek – Efek Sampingnya. Jakarta : PT.Elex Media Komputindo
Tugasworo D. (2002). Prevensi sekunder stroke dalam Management of Post Stroke. Di dalam : Temu Regional Neurologi Jateng-DIY ke XIX
“Neurology-update”. Semarang: Badan Penerbit UNDIP
Terjadinya Stroke Berulang pada Penderita Stroke di Poliklinik Saraf RSUP DR. M.Jamil Padang. Padang: STIKES Keperawatan Mercubaktijaya
Westendorp WF, Vermeij JD, Dippel DW, Dijkgraaf MG, Van der Poll T, et al. (2014). Update of the preventive antibiotics in stroke study (PASS): statistical analysis plan. Volume 15:382.
Wibisono, Ananta. 2012. Hubungan Fibrilasi Atrium Dengan Kejadian Stroke Iskemik di RSUD Dr. Moewardi. Naskah Publikasi. Fakultas Kedokteran, Universitas Muhammadiyah Surakarta
Windartha Iwan Permana., Wiratmo, Prihwanto Budi S., Fifteen Aprila Fajrin, Siti Muslichah. Identifikasi Potensi Drug Related Problems (DRP) Pada Pasien Stroke Non Hemoragik di RSD dr. Soebandi Jember Periode 1 Januari – 31 Desember 2012. Artikel Ilmiah Hasil Penelitian Mahasiswa 2013
WHO [World Health Organization].2005. Preventing Chronic Disease a Vital Investement. World Health Organization : Switzerland. Diakses
http://www.who.int/chp/chronic_disease_report/en/ pada 29 November 2016 pukul 15.05 WIB
Wulandari, Andhika Restu. 2011. Pengaruh Terapi Piracetam dan atau Citicolin Pada Kemampuan Motorik Penderita Stroke di RSD dr Soebandi Jember dengan Parameter GCS. Skripsi. Universitas Jember : Fakultas Farmasi.
Van de Beek D. Wijdicks EFM. Vermeij, FH. de Haan RJ, Prins JM,
Spanjaard L, et al. (2009). Preventive antibiotics for infections in acute stroke; A systematic review and meta-analysis. Arrachive of Neurology. Volume 66(9): 1076-81.
Y Koh , Kutty FB, Li SC:Drug-related problems in hospitalized patients on polypharmacy: The influence of age and gender. J Therapeut Clin Risk Manag2005,1:39–48
